Content about Heart Protection Study

June 9, 2011

The Food and Drug Administration is seeking to limit the use of high doses of a drug for high cholesterol due to the risk of a muscle injury known as myopathy.

SILVER SPRING, Md. — The Food and Drug Administration is seeking to limit the use of high doses of a drug for high cholesterol due to the risk of a muscle injury known as myopathy.

March 21, 2010

Merck & Co. has responded to a warning by the Food and Drug Administration about...

March 18, 2010

Patients taking a common drug for treating high cholesterol may be at increased risk of...